NR3C2 and type 2 diabetes mellitus: The present results are supported by previous findings in other patient groups (Adachi et al., 2019; Hwang et al., 2015), but it remains unknown if a longer duration of MR blockade or MR blockade in other stages of T2D, would have a different outcome than the present results.